US health experts to recommend coronavirus vaccine booster shots for all Americans 8 months after receiving their second dose; 5 states report record 7-day averages of new daily cases of COVID-19; debunking concerns of people receiving blood transfusions from vaccinated individuals.
As reported by The Associated Press, US health experts are expected to recommend that all Americans get a COVID-19 vaccine booster shot 8 months of receiving a second dose of their initial vaccine. Although health officials have maintained that fully vaccinated persons remain protected against severe disease, including the delta variant, they also note this decision was made as a way to prepare for the possibility of when efficacy begins to diminish. Nationwide administration of doses is said to begin once the FDA formally approves the vaccines, which is expected in the coming weeks for the Pfizer shot. For those who received the 1-shot Johnson & Johnson vaccine, a timeline on when they should receive a booster dose is still under consideration.
Over the weekend, 5 states reported record highs in their 7-day COVID-19 case averages, as strained hospital systems have forced several states to reinstate public health restrictions amid the delta variant surge. Reported by CNBC, record case peaks were observed in Hawaii, Oregon, Florida, Louisiana, and Mississippi as of Sunday, with the latter 3 states noted to be suffering from the worst outbreaks nationwide. Worldwide, the CDC added 4 destinations to its very high COVID-19 travel risk list: Turkey, Montenegro, Dominica, and the island of Jersey (just off France's coast).
As division on COVID-19 vaccine adherence continues to garner debate across the country, an article by Kaiser Health News reports that skepticism on the shots has led patients to demand blood transfusions, when needed, from unvaccinated individuals, which blood centers insisted is not medically sound or operationally feasible. Responding to patients worried that vaccinated blood would be tainted, Red Cross officials have said that COVID-19 vaccines, which are injected into the muscle or the layer of skin below, does not circulate in the blood.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More